Stay updated with breaking news from Pascal Deschatelets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Teacher Retirement System of Texas grew its stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 5.5% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,099 shares of the company’s stock after purchasing an additional 1,203 shares during the quarter. […]
Assenagon Asset Management S.A. lifted its stake in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 105.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 1,023,507 shares of the company’s stock after acquiring an additional 524,797 shares during the quarter. Assenagon Asset Management S.A. […]
Assenagon Asset Management S.A. raised its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 105.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,023,507 shares of the company’s stock after acquiring an additional 524,797 shares during the quarter. Assenagon Asset Management […]
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its price target hoisted by HC Wainwright from $82.00 to $92.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock. APLS has been the subject of a number of other reports. Wells Fargo & Company downgraded […]
Jacob Asset Management of New York LLC raised its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) by 1,017.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,850 shares of the company’s stock after buying an additional 4,416 shares during the quarter. […]